60 Results for "

PANC1 cells

" in MedChemExpress (MCE) Product Catalog:
Products (60)

60 Results for "PANC1 cells" in MCE Product Catalog:

15
15 Publications Verification
Cat. No.: HY-18597
CAS No.: 1632032-53-1
Target:  

Phosphatase

Research Areas:  

Cancer

LB-100 is a protein phosphatase 2A (PP2A) inhibitor, with IC50 of 0.85 μM and 3.87 μM in BxPc-3 and Panc-1 cells .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-19357
CAS No.: 136164-66-4
Synonyms: E3330; APX-3330
Erenapursta (E3330) is a direct, orally active and selective inhibitor of Ape-1 (apurinic/apyrimidinic endonuclease 1)/Ref-1 (redox factor-1) redox. Erenapursta is able to impair tumor growth and blocks the activity of NF-κB, AP-1, and HIF-1α in pancreatic cancer. Erenapursta shows anticancer activities .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-19352
CAS No.: 924473-59-6
Synonyms: T5601640
Target:  

LIM Kinase (LIMK)

Research Areas:  

Cancer

T56-LIMKi is a selective inhibitor of LIMK2; inhibits the growth of Panc-1 cells with an IC50 of 35.2 μM.
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-B1152
CAS No.: 3819-00-9
Piperacetazine is an orally active dopamine receptor antagonist and phenothiazine antipsychotic. Piperacetazine can directly bind to the PAX3::FOXO1 fusion protein and inhibit its transcriptional activity. Piperacetazine also exhibits antitumor activity with an IC50 of 7.627 μM against PANC-1 cells. Piperacetazine can be used for the research of diseases such as schizophrenia and pancreatic cancer and other tumors .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-N1410
CAS No.: 42206-94-0
Triacetylresveratrol, an acetylated analog of Resveratrol. Triacetylresveratrol decreases the phosphorylation of STAT3 and NF-κB in a dose- and time- dependent manner in PANC-1 and BxPC-3 cells. Anticancer effects .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-135680
CAS No.: 1094048-77-7
Purity:  98.03%
Synonyms: I-OMe-AG 538
Target:  

IGF-1R

Research Areas:  

Metabolic Disease Cancer

I-OMe-Tyrphostin AG 538 (I-OMe-AG 538) is a specific inhibitor of IGF-1R (insulin-like growth factor-1 receptor tyrosine kinase). I-OMe-Tyrphostin AG 538 inhibits IGF-1R-mediated signaling and is preferentially cytotoxic to nutrient-deprived PANC1 cells.?I-OMe-Tyrphostin AG 538 is an ATP-competitive inhibitor of phosphatidylinositol-5-phosphate 4-kinase α (PI5P4Kα), with an IC50?of 1 μM .
loading...
    loading...
Cat. No.: HY-113978
CAS No.: 712-30-1
Purity:  ≥98.0%
6-Formylpterin is an inhibitor of Xanthine Oxidase. 6-Formylpterin induces intracellular ROS generation and apoptosis in HL-60 cells. 6-Formylpterin suppresses cell proliferation in PanC-1 cells .
loading...
    loading...
Cat. No.: HY-113314
CAS No.: 52450-38-1
Purity:  99.77%
AFMK, antioxidant metabolite of Melatonin, attenuates X-ray-induced oxidative damage to DNA, proteins and lipids in mice. AFMK is a poorer scavenger. The pKa of AFMK at physiological pH is 8.7. Antioxidant capacity . AFMK improves the anti-tumor effect of Gemcitabine in PANC-1 cells through the modulation of apoptotic pathway .
loading...
    loading...
Cat. No.: HY-152261
CAS No.: 2891709-58-1
Purity:  99.2%
Research Areas:  

Cancer

MS6105 is a PROTAC degrader targeting LDHA and LDHB, with DC50 values of 38 nM and 74 nM for degrading LDHA and LDHB in PANC-1 cells, respectively, and no hook effect is observed at high concentrations. MS6105 inhibits the proliferation of pancreatic cancer cells, and no obvious toxicity is observed after intraperitoneal administration in mice. MS6105 can be used for pancreatic cancer-related research .
loading...
    loading...
Cat. No.: HY-125221
CAS No.: 1681020-24-5
Purity:  98.48%
Research Areas:  

Cancer

DJ4 is a ATP-competitive inhibitor of ROCK1/2 (IC50 values:5 and 50 nM) and MRCKα/β (IC50 values:10 and 100 nM). DJ4 blocks stress fiber formation and inhibits migration and invasion of cancer cells. DJ4 can be used for study of lung cancer, breast cancer, and pancreatic (PANC-1) cancer .
loading...
    loading...
Cat. No.: HY-144661
CAS No.: 2765254-39-3
Purity:  99.39%
Target:  

Ras Apoptosis

Research Areas:  

Cancer

KRAS G12D inhibitor 14 is a potent KRAS G12D inhibitor with a KD of 33 nM for binding to KRAS G12D protein. KRAS G12D inhibitor 14 decreases the active form of KRAS G12D (KRAS G12D-GTP) but not KRAS G13D .
loading...
    loading...
Cat. No.: HY-152204
CAS No.: 3052930-88-5
Target:  

Cathepsin

Research Areas:  

Cancer

Cathepsin L/S-IN-1 is a dual inhibitor of Cathepsin L and Cathepsin S with IC50s of 4.10 μM and 1.79 μM, respectively. Cathepsin L/S-IN-1 shows a significant antimetastatic and invasive effects on pancreatic cancer BxPC-3 and PANC-1 cells .
loading...
    loading...
Cat. No.: HY-143657
CAS No.: 2366279-99-2
Purity:  99.88%
Target:  

Myosin Ferlin Family MMP

Research Areas:  

Cancer

Myoferlin inhibitor 1 is a compound that exhibits reversible, concentration-dependent binding to the myoferlin MYOF-C2D protein, with a KD of 0.094 μM. Myoferlin inhibitor 1 shows potent anti-invasion and anti-migration activities against different pancreatic cancer cells. Myoferlin inhibitor 1 inhibits pancreatic cancer metastasis through reversing mesenchymal transition (EMT), inhibiting the secretions of MMP1 and MMP2 and blocking the receptor tyrosine kinases. Myoferlin inhibitor 1 displays effective antimetastatic activities in pancreatic cancer in vitro and in vivo. Myoferlin inhibitor 1 can be used in research on preventing pancreatic cancer metastasis .
loading...
    loading...
Cat. No.: HY-N7287
CAS No.: 148409-36-3
(+)-Matairesinol is a lignan. (+)-Matairesinol has no cytotoxic activity for human pancreatic PANC-1 cancer cells .
loading...
    loading...
Cat. No.: HY-127155
CAS No.: 680571-51-1
Kigamicin C is an anti-tumor antibiotic that selectively kills pancreatic cancer PANC-1 cells only in nutrient-poor conditions. Kigamicin C has antimicrobial activity against Gram-positive bacteria including methicillin-resistant Staphylococcus aureus (MRSA) .
loading...
    loading...
Cat. No.: HY-175224
Research Areas:  

Cancer

PROTAC BRD4 Degrader-36 is a BRD4 PROTAC degrader with a DC50 of 0.649 nM. It has a Kd of 123 nM for TRIM21. PROTAC BRD4 Degrader-36 recruits the E3 ubiquitin ligase TRIM21 (Kd = 123 nM) to BRD4, leading to ubiquitination and subsequent degradation of BRD4. PROTAC BRD4 Degrader-36 exhibits cytotoxicity against PANC-1 cells (GI50 = 0.103 μM). It can be used in research related to pancreatic cancer .
loading...
    loading...
Cat. No.: HY-P5291
CAS No.: 103238-06-8
Synonyms: Caerulein precursor fragment
Target:  

Insulin Receptor

Research Areas:  

Metabolic Disease

CPF-7 (Caerulein precursor fragment) is an insulin-releasing peptide that stimulates the release of insulin. CPF-7 can induce epithelial-mesenchymal transition by upregulating Snai1 expression in PANC-1 ductal cells. CPF-7 also induces exocrine plasticity by upregulating Ngn3 expression. CPF-7 can be used in the research of type 2 diabetes .
loading...
    loading...
Cat. No.: HY-113978R
CAS No.: 712-30-1
6-Formylpterin (Standard) is the analytical standard of 6-Formylpterin. This product is intended for research and analytical applications. 6-Formylpterin is an inhibitor of Xanthine Oxidase. 6-Formylpterin induces intracellular ROS generation and apoptosis in HL-60 cells. 6-Formylpterin suppresses cell proliferation in PanC-1 cells .
loading...
    loading...
Cat. No.: HY-175398
CAS No.: 2201798-21-0
Research Areas:  

Cancer

OZO-Cl is an OZO derivative. OZO-Cl has anti-cancer activity. OZO-Cl significantly decreases the intracellular glutathion S-transferase Pi (GST) activity. OZO-Cl exhibits cytotoxicity to cancer cell lines, with IC50s of 150 and 120 μmol/L in Panc-1 and K562 cells respectively .
loading...
    loading...
Cat. No.: HY-157740
Target:  

HDAC

Research Areas:  

Cancer

XSJ-10 is a HDAC inhibitor containing a RAS/RAF protein interfering unit, with IC50s of 0.05 and 0.04 μM in PANC-1 cells and HT-29 cells. XSJ-10 can effectively induce the apoptosis of cancer cells and suppress the tumor by strongly inhibiting the RAS-RAF-MEK-ERK signaling pathway and the acetylation level of HDAC3 .
loading...
    loading...